 "Recipharm buys 74% stake in Nitin Lifesciences for Rs 671 crore")
Hester Biosciences today reported a 57.14 per cent rise in standalone net profit to Rs 5.5 crore for the quarter ended March 31.
The company had posted a net profit of Rs 3.5 crore in the same quarter last fiscal, Hester Biosciences said in a BSE filing.
Standalone net sales of the company rose to Rs 28.18 crore for quarter under review as against Rs 23.36 crore in the year-ago period.
For entire 2015-16 fiscal, the standalone net profit of the firm surged to Rs 19.22 crore compared with Rs 13.99 crore a year ago.
Its standalone net sales for the fiscal increased to Rs 100.89 crore from Rs 90.03 crore in the preceding fiscal.
In a separate filing, Hester Biosciences said its Board of Directors has recommended a final dividend of Rs 1.10 per equity share for 2015-16 fiscal.
